• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Barotrauma, invasive ventilation, and timing of tocilizumab as predictors of mortality along with inflammatory markers and comorbidities in critically ill COVID-19 patients: A retrospective study.

作者信息

Zirpe Kapil, Gurav Sushma, Deshmukh Abhijit, Wankhede Prajakta

机构信息

Neurotrauma Unit (NTU), Ruby Hall Clinic, Grant Medical Foundatation, Pune, Maharashtra, India.

出版信息

Indian J Anaesth. 2021 Oct;65(10):755-759. doi: 10.4103/ija.ija_637_21. Epub 2021 Oct 29.

DOI:10.4103/ija.ija_637_21
PMID:34898703
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8607865/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a08/8607865/eb593f29722c/IJA-65-755-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a08/8607865/eb593f29722c/IJA-65-755-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a08/8607865/eb593f29722c/IJA-65-755-g001.jpg

相似文献

1
Barotrauma, invasive ventilation, and timing of tocilizumab as predictors of mortality along with inflammatory markers and comorbidities in critically ill COVID-19 patients: A retrospective study.在危重症新型冠状病毒肺炎患者中，气压伤、有创通气、托珠单抗的使用时机作为死亡率的预测因素以及与炎症标志物和合并症的关系：一项回顾性研究
Indian J Anaesth. 2021 Oct;65(10):755-759. doi: 10.4103/ija.ija_637_21. Epub 2021 Oct 29.
2
Occurrence, Risk Factors, and Outcomes of Pulmonary Barotrauma in Critically Ill COVID-19 Patients: A Retrospective Cohort Study.危重症新型冠状病毒肺炎患者肺气压伤的发生率、危险因素及预后：一项回顾性队列研究
Crit Care Res Pract. 2023 Feb 22;2023:4675910. doi: 10.1155/2023/4675910. eCollection 2023.
3
Incidence, clinical characteristics and outcome of barotrauma in critically ill patients with COVID-19: a systematic review and meta-analysis.COVID-19 重症患者气压伤的发生率、临床特征和转归：系统评价和荟萃分析。
Minerva Anestesiol. 2022 Sep;88(9):706-718. doi: 10.23736/S0375-9393.22.16258-9. Epub 2022 Apr 13.
4
Outcomes of Barotrauma in Critically Ill COVID-19 Patients With Severe Pneumonia.危重症 COVID-19 合并严重肺炎患者气压伤的转归。
J Intensive Care Med. 2021 Oct;36(10):1176-1183. doi: 10.1177/08850666211023360. Epub 2021 Jun 21.
5
Tocilizumab in critically ill COVID-19 patients: An observational study.托珠单抗用于危重症 COVID-19 患者：一项观察性研究。
Int Immunopharmacol. 2022 Jan;102:108384. doi: 10.1016/j.intimp.2021.108384. Epub 2021 Nov 20.
6
Tocilizumab for the Critically Ill With Severe COVID-19: A Community Hospital Case Series.托珠单抗治疗重症 COVID-19 患者：社区医院病例系列研究。
J Pharm Pract. 2022 Aug;35(4):587-592. doi: 10.1177/08971900211002353. Epub 2021 Mar 19.
7
Pulmonary Barotrauma in COVID-19 Patients With ARDS on Invasive and Non-Invasive Positive Pressure Ventilation.COVID-19 患者合并急性呼吸窘迫综合征在有创和无创正压通气时的肺气压伤。
J Intensive Care Med. 2021 Sep;36(9):1013-1017. doi: 10.1177/08850666211019719. Epub 2021 May 20.
8
Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.托珠单抗与新冠病毒病合并急性肾衰竭重症患者真菌感染风险增加相关：一项观察性队列研究
Life (Basel). 2023 Aug 16;13(8):1752. doi: 10.3390/life13081752.
9
Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS-CoV-2.托珠单抗治疗感染 SARS-CoV-2 的危重症患者。
Clin Transl Sci. 2021 Nov;14(6):2146-2151. doi: 10.1111/cts.12894. Epub 2021 Oct 27.
10
Tocilizumab Use in COVID-19 Cytokine-release Syndrome: Retrospective Study of Two Centers.托珠单抗用于治疗新冠病毒感染细胞因子释放综合征：两个中心的回顾性研究
Indian J Crit Care Med. 2020 Sep;24(9):771-776. doi: 10.5005/jp-journals-10071-23566.

引用本文的文献

1
Tocilizumab in severe COVID-19 pneumonia: A retrospective case-control study from eastern India.托珠单抗治疗重症新型冠状病毒肺炎：一项来自印度东部的回顾性病例对照研究。
Indian J Anaesth. 2023 Jul;67(7):647-650. doi: 10.4103/ija.ija_157_23. Epub 2023 Jul 14.
2
Optimising clinical outcomes with innovative research in the intensive care unit.通过重症监护病房的创新研究优化临床结果。
Indian J Anaesth. 2022 Aug;66(8):549-552. doi: 10.4103/ija.ija_690_22. Epub 2022 Aug 22.
3
Pulmonary Barotrauma in COVID-19 Patients: Experience From a Secondary Care Hospital in Oman.

本文引用的文献

1
COVID-19: A game of drugs, vaccines, hope and… death!新冠疫情：一场关乎药物、疫苗、希望以及……死亡的博弈！
Indian J Anaesth. 2021 Jun;65(6):434-438. doi: 10.4103/ija.ija_508_21. Epub 2021 Jun 22.
2
Second wave of COVID-19 pandemic and the surge of mucormycosis: Lessons learnt and future preparedness: Indian Society of Anaesthesiologists (ISA National) Advisory and Position Statement.新型冠状病毒肺炎大流行的第二波及毛霉菌病激增：经验教训与未来防范：印度麻醉医师协会（印度麻醉医师协会全国委员会）咨询意见和立场声明
Indian J Anaesth. 2021 Jun;65(6):427-433. doi: 10.4103/ija.ija_520_21. Epub 2021 Jun 22.
3
Case fatality and recovery rate of COVID 19: What are we missing?
新型冠状病毒肺炎患者的肺气压伤：阿曼一家二级护理医院的经验
Cureus. 2022 Jun 29;14(6):e26414. doi: 10.7759/cureus.26414. eCollection 2022 Jun.
新冠病毒病的病死率和康复率：我们遗漏了什么？
Indian J Anaesth. 2021 May;65(Suppl 2):S95-S97. doi: 10.4103/ija.IJA_59_21. Epub 2021 May 10.
4
Clinical outcomes of using remdesivir in patients with moderate to severe COVID-19: A prospective randomised study.瑞德西韦治疗中重度新型冠状病毒肺炎患者的临床疗效：一项前瞻性随机研究。
Indian J Anaesth. 2021 Mar;65(Suppl 1):S41-S46. doi: 10.4103/ija.IJA_149_21. Epub 2021 Mar 20.
5
Predictive factors of six-week mortality in critically ill patients with SARS-CoV-2: A multicenter prospective study.新型冠状病毒肺炎危重症患者6周死亡率的预测因素：一项多中心前瞻性研究。
Med Intensiva (Engl Ed). 2021 Mar 8;46(4):179-91. doi: 10.1016/j.medin.2021.02.013.
6
High Incidence of Barotrauma in Patients With Severe Coronavirus Disease 2019.严重 COVID-19 患者中气压伤发生率较高。
J Intensive Care Med. 2021 Jun;36(6):646-654. doi: 10.1177/0885066621989959. Epub 2021 Mar 15.
7
Does timing matter on tocilizumab administration? Clinical, analytical and radiological outcomes in COVID-19.托珠单抗给药时机是否重要？COVID-19 中的临床、分析和影像学结果。
Eur J Hosp Pharm. 2022 Nov;29(6):340-345. doi: 10.1136/ejhpharm-2020-002669. Epub 2021 Feb 24.
8
Prevalence and risk factors of barotrauma in Covid-19 patients admitted to an intensive care unit in Kuwait; a retrospective cohort study.科威特一家重症监护病房收治的新冠肺炎患者气压伤的患病率及危险因素；一项回顾性队列研究。
Ann Med Surg (Lond). 2021 Mar;63:102141. doi: 10.1016/j.amsu.2021.01.089. Epub 2021 Feb 5.
9
Association of elevated inflammatory markers and severe COVID-19: A meta-analysis.炎症标志物升高与重症新型冠状病毒肺炎的关联：一项荟萃分析。
Medicine (Baltimore). 2020 Nov 20;99(47):e23315. doi: 10.1097/MD.0000000000023315.
10
Mortality of Patients With Severe COVID-19 in the Intensive Care Unit: An Observational Study From a Major COVID-19 Receiving Hospital.重症监护病房中重症新型冠状病毒肺炎患者的死亡率：来自一家主要的新型冠状病毒肺炎收治医院的观察性研究
Cureus. 2020 Oct 12;12(10):e10906. doi: 10.7759/cureus.10906.